KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Change in Acquisitions & Divestments (2016 - 2025)

Cvs Health (CVS) has disclosed Change in Acquisitions & Divestments for 15 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 0.88% year-over-year to $2.7 billion, compared with a TTM value of $12.4 billion through Dec 2025, up 19.61%, and an annual FY2025 reading of $12.4 billion, up 19.61% over the prior year.
  • Change in Acquisitions & Divestments was $2.7 billion for Q4 2025 at Cvs Health, down from $2.8 billion in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $3.5 billion in Q1 2025 and bottomed at $1.2 billion in Q3 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 36.98% in 2021, then surged 82.75% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $1.7 billion in 2021, then dropped by 29.22% to $1.2 billion in 2022, then soared by 82.75% to $2.2 billion in 2023, then grew by 24.61% to $2.7 billion in 2024, then increased by 0.88% to $2.7 billion in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for CVS at $2.7 billion in Q4 2025, $2.8 billion in Q3 2025, and $3.3 billion in Q2 2025.